HOME » ATNAA (Antidote Treatment Nerve Agent Auto-Injector)

ATNAA
(Antidote Treatment Nerve Agent Auto-Injector)
(atropine and pralidoxime chloride injection)

  • NSN: 6505-01-362-7427
  • NDC: 11704-77-01
  • Delivers: Using the two chamber BinaJect™ drug delivery system, delivers 2.1 mg atropine in 0.7 mL and 600 mg pralidoxime chloride in 2 mL sequentially using a single needle
  • Indications: Antidote for organophosphorous
    (nerve agent/insecticide) poisoning.
  • Packaged: 100 auto-injectors/ box
  • Export License: Required
  • Package Insert

BinaJect™ is a trademark of Meridian Medical Technologies™, Inc. in the United States of America.

IMPORTANT SAFETY INFORMATION: Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments including masks designed specifically for this use. Individuals should not rely solely upon antidotes such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Seek immediate medical attention after injection with antidotes.

PN MMT3705 © 2007 Meridian Medical Technologies™, Inc. a subsidiary of King Pharmaceuticals®, Inc.